Skip to main content

Published locations for Tivantinib plus erlotinib may benefit high MET expression non–small cell lung cancers

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Tivantinib plus erlotinib may benefit high MET expression non–small cell lung cancers

User login

  • Reset your password
  • /content/tivantinib-plus-erlotinib-may-benefit-high-met-expression-non-small-cell-lung-cancers
  • /oncologypractice/article/78493/lung-cancer/tivantinib-plus-erlotinib-may-benefit-high-met-expression
  • /hematology-oncology/article/78493/lung-cancer/tivantinib-plus-erlotinib-may-benefit-high-met
  • /chestphysician/article/78493/lung-cancer/tivantinib-plus-erlotinib-may-benefit-high-met-expression